Home › NDC Lookup › RxCUI directory › RxCUI 1090996

Ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Jinteli] — RxCUI 1090996

RxNorm drug concept · Semantic branded drug
RxCUI 1090996 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1090996
Official nameEthinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Jinteli]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asJinteli 1 MG / 5 MCG Oral Tablet; Jinteli 1/5 (ethinyl estradiol 5 MCG / norethindrone acetate 1 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)139 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norethindrone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Most norethindrone tablets — including brands like Camila, Errin, Emzahh, and Affodel — are progestin-only birth control pills taken daily to prevent pre...
  • Regular combination birth control pills contain two hormones — estrogen and progestin. Norethindrone is a progestin-only pill, sometimes called the 'mini-pill.' Because it has no e...
  • How is this different from regular birth control pills?
  • The most common thing people notice is irregular bleeding — spotting between periods, or changes in your cycle. Headache, breast tenderness, nausea, and dizziness are also reported...
📖 Read our full Norethindrone guide →

🕸️ Concept Web — How Ethinyl estradiol 0.005 MG / norethindrone aceta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG Oral Tablet [Jinteli] RxCUI 1090996

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Ethinyl estradiol 4124
    • Norethindrone 7514
    • Ethinyl estradiol / norethindrone 384410
    • Norethindrone acetate 31983
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Jinteli 1090993
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ethinyl estradiol / norethindrone Oral Tablet 372105
    • Ethinyl estradiol / norethindrone acetate Oral Tablet 2648046
    • Ethinyl estradiol / norethindrone Oral Product 1157354
    • Ethinyl estradiol / norethindrone Pill 1157355
    • Ethinyl estradiol / norethindrone acetate Oral Product 2661574
    • Ethinyl estradiol / norethindrone acetate Pill 2661136
    • Ethinyl estradiol / norethindrone Oral Tablet [Jinteli] 1090995
    • Ethinyl estradiol / norethindrone acetate Oral Tablet [Jinteli] 2656520
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Ethinyl estradiol 0.005 MG / norethindrone acetate 1 MG [Jinteli] SBDC · 1090994
  • Ethinyl estradiol / norethindrone Oral Tablet [Jinteli] SBDF · 1090995
  • Ethinyl estradiol / norethindrone acetate Oral Tablet [Jinteli] SBDFP · 2656520
  • Jinteli Oral Product SBDG · 1167867
  • Jinteli Pill SBDG · 1167868
  • Jinteli BN · 1090993

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1090996 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-3122-42 5 BLISTER PACK in 1 CARTON (0093-3122-42) / 28 TABLET in 1... Jinteli Teva Pharmaceuticals USA, Inc. 2011-02-17
00093-3122-98 90 TABLET in 1 BOTTLE (0093-3122-98) Jinteli Teva Pharmaceuticals USA, Inc. 2011-02-17
Observed labelers: Teva Pharmaceuticals USA, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.7077
Range $0.7077–$0.7077 · middle 50% $0.7077–$0.7077 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.